Taiko Pharmaceutical Listed On Tokyo Stock Exchange
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Japanese drug maker Taiko Pharmaceutical was listed March 18 on the second division of Tokyo Stock Exchange. Known for digestive medicine Seirogan in Japan, Taiko plans to use the raised funds to promote avian flu virus treatments. (Click here for more - Japanese language